chrisvoncsefalvay/vaers-outcomes huggingface dataset:
About 5 minutes after recieving the vaccine, pt began sweating and was dizzy, out of breath, and nauseous. Symptoms resolved within 10 minutes.
INFLUENZA VIRUS POSITIVE; FEVER; TESTED NEGATIVE FOR COVID-19; A spontaneous report has been received from a health professional. The report concerns a male patient (height 51 in, weight 68 lb).    No medical history was reported.     No concomitant products were reported.    On 16-Oct-2020, the patient received Flumist Quadrivalent (influenza virus vaccine live, intranasal) (batch number MH2024) 0.2 ml as required, via nasal route, for prevention.     On 19-Oct-2020 patient returned to medical office with fever (preferred term: Pyrexia) of 103 degrees Fahrenheit and tested positive for A strain of the influenza virus (preferred term: Influenza A virus test positive). Both parents of the patient tested positive for Covid-19, although patient tested negative for Covid-19 (preferred term: SARS-CoV-2 test negative).    The outcome of the events of influenza virus positive, fever and tested negative for covid-19 was unknown.     The event of tested negative for covid-19 have been identified by the company physician from the source document and added as adverse event.    Company physician assessed the event of tested negative for covid-19  as non serious. The event of influenza virus positive considered serious due to important medical event and the event of fever was considered as non serious by the reporter.; Sender's Comments: Influenza A virus test positive is not listed in the core company data sheet for flumist quadrivalent (Q/Laiv). Due to limited information on event details including the circumstances leading to the event, relevant medical history, concomitant medications, concurrent conditions (pulmonary and immune system disorders), discussion on lifestyle and specific risk factors (contact with infected person with known influenza), it is not possible to make a conclusive assessment of the causal relationship between the event and the suspect drug.
Just usual soreness/ Pain went away; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Just usual soreness/ Pain went away) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Just usual soreness/ Pain went away). At the time of the report, MYALGIA (Just usual soreness/ Pain went away) had resolved. Not Provided          No concomitant medication was reported. No treatment medication was reported. The patient had usual soreness and no medication was needed with no swelling. The pain went away in about two days.   This case was linked to MOD-2021-411485, MOD-2021-406511 (Patient Link).
gave the patient only the diluent portion of the Arexvy vaccine; I got distracted and gave the patient only the diluent portion of the Arexvy vaccine; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   On 08-SEP-2023, the patient received Arexvy. On 08-SEP-2023, an unknown time after receiving Arexvy, the patient experienced inappropriate preparation of medication (Verbatim: gave the patient only the diluent portion of the Arexvy vaccine) and inappropriate dose of vaccine administered (Verbatim: I got distracted and gave the patient only the diluent portion of the Arexvy vaccine).  The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK receipt date: 09-SEP-2023 The reporter left message on after hours VM box, that he got distracted and gave the patient only the diluent portion of the Arexvy vaccine. The reporter contacted provided permission for Safety team follow-up for additional patient details & adverse event details. The reporter consented to follow up. The reporter left message on after hours VM box, that he got distracted and gave the patient only the diluent portion of the Arexvy vaccine, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
Very itchy right ear lobe, few days later also right cheek was itching, a week later also right jaw was itching, two weeks later also right collar bone was itching. I didn't report this at the time because I didn't think it came from the Vaccine. I still have the same symptoms and began to wonder if others have the same condition. Condition is worse in the morning. Affected areas also tingle at times. Condition is much better after about 10am. I have not talked to a doctor yet because it is not a servere experience. During my annual physical exam in July I will talk to my doctor about it.
Arm pit/ lymph node pain; Arm pit/ lymph node pain; "Dose 1, administration date: 29Mar2021 at 08:30; Dose 2, administration date: 16Apr2021 at 18:00"; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 16Apr2021 at 18:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included depression. Concomitant medications included fluoxetine hydrochloride (PROZAC), quetiapine fumarate (SEROQUEL) and amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL); all taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 29Mar2021 at 08:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 18:00 the patient had "Dose 1, administration date: 29Mar2021 at 08:30; Dose 2, administration date: 16Apr2021 at 18:00". On 17Apr2021 at 03:00, the patient experienced arm pit/ lymph node pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events arm pit/ lymph node pain was resolving at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
15 minutes after vaccine given, complaints of chest pressure/tightness, tachycardia -pulse=120, c/o forehead pressure.   Team called, sent to ED
Developed UTI 3 days after vaccination. Having back, kidney area discomfort. Treated with antibiotic
This spontaneous report as received from a healthcare worker refers to unspecified number of patients of unknown demographics. On an unknown date, unspecified number of patients might have been vaccinated with PEDVAXHIB (dose, lot and expiry date were not reported) that have been exposed to unsupported temperature excursions. No adverse effect was reported. This is 1 of 3 reports from same reporter. Additional information has been requested.
Bell's Palsy was diagnosed at ER on 4/2/2021. was put on medium dose of prednisone - 20 mg  2 tablets per day for 6 days.  Symptoms are left side of face is drooping , taste changes, trouble talking and eating. watering eye on left side. Inability to close my left eye. was given erythromycin to add to eye and was told to tape it shut when sleeping.
This spontaneous report as received from a registered nurse refers to a 7 month 24 days old patient (gender unspecified). In approximately July 2012, the patient was vaccinated with a dose of hepatitis A vaccine, inactivated (manufacturer unspecified, but VAQTA could not be ruled out) at 7 months 24 days of age. Lot # and administration route were unspecified. On 12-FEB-2013, the physician administered a dose of VAQTA (25U/0.5ml injection) for vaccination to the patient (patient was noted as being 1 year 2 months of age at the time of the report). The physician and office associated with the case was not the office or physician that administered the Hepatitis A vaccine (manufacturer unspecified) to the patient at 7 months 24 days (name of office or physician was unspecified). No adverse event reported. Additional information is not expected.
Shortly after being given the first dose of the Shingrix (Herpes Zoster) vaccine I started itching on my legs mostly on the right) and about my belt line on my back. The legs which I could see had small reddish bumps on them. When my arrived back at the house on Sunday (out of town) I ask her to look at my back and she said it had a rash like irritation at that location. After telling her that I had received the Shingles vaccine on Thursday night we both agreed that I should call our doctor and have her look at it. I called on Monday and was issued an appointment on Tuesday. It was confirmed by the doctor that I had shingles on my back but she was not 100% sure what was causing the bumps and itching on my leg. I was given a prescription and it got better  after a couple of weeks.
Patient received COVID-19 booster and flu vaccine, one each arm.  Within a few minutes, complained of chest tightness and SOB. (history of asthma) Vitals: Pulse 76, BP 130/80 O2 100%, respirations 16. Patient used her inhaler and was given a drink of water. After 5 more minutes patient vitals remained the same and patient said she was feeling better. Left after wait period with adult son, agreed to watch for further symptoms and seek medical care if necessary.
Local reaction at injection site and diffuse macular papular rash develop approximately 48 hours after injection was on 2 antibiotics so with if rash Dpt.
Family member reported to this Nursing Supervisor patient suffered stroke 04/13/2021 at the patients home. Family discovered patient 04/14/2021 and taken to Hospital then life flighted to another hospital. Family reports he has left sided paralysis, slurred speech, nasogastric tube placement and currently in neuro ICU.
No adverse effects during or after shots. Two months later I had a detached retina. This is the 2nd time I've needed a retinal repair, the first time was about 2 years ago. This event seems unrelated to the vaccine but thought I should report anyway.
Within minutes, flush down the body. Then a very funny taste in my mouth (lasting several days). Within a few more minutes, rapid heartbeat with some intermittent skipping (lasted for 4 hours). Complete loss of appetite (lasted for several days). Couldn't lift left for two days. During the week from time of injection, one day of fatigue.
This patient was given a dose that was expired. The ActHib vaccine had expired on 3/7/21 and it was administered on 3/19/21. There were no adverse symptoms observed. The patient has been notified and scheduled for a new ActHib vaccination.
I got Covid Arm big red itchy circle on arm the next day after injection and now it is 9 days later, I still have it. I took a picture today. I'm not allergic to anything. But I did have Epstein-Barr Syndrome about 30 years ago...directly after 3rd dose of a vaccine. So I am worried about shot #2.
When administering the vaccination, the seal between the syringe and needle was compromised and an indeterminate amount of vaccine leaked out the side of the syringe/needle.
Pt received FLUZONE vaccine on 10/18/11. She then returned home and awoke on 10/20/11 with swollen face/lips. Pt advised to take BENADRYL, call doctor/go to hospital.
Severe Diarrhea for 27 days Severe muscle contraction, stiffness, and pain on neck, shoulders, back, and chest for 7 days Hot flashes Night & day sweats Weight loss
Painful red patch at site of injection appeared about 12 hours after injection. The red patch has become itchy and remains itchy two days after the injection.
47 y/o male who received Smallpox vaccine on 13 MAR 03.  Nine days after vaccination, soldier experienced a bump in his left nostril associated with c/o soreness. Within two days, 2-3 mm vesicles developed in his nostril and on his distal left nose, which became slightly larger, coalesced and became pustular.  Pt notes a mild take on his vaccination in left deltoid area, which was nearly completely healed at the time he developed his Rash on the nose.  He denies pain, fevers or other rashes.  He has no history of rashes on skin, though does have a history of sarcoidosis.
Axillary node swelling under vaccinated arm.  It has been one month and I still have swelling and pain under my arm, on the side of my left breast and in my chest.  I have radiating pain up my shoulder where I was vaccinated and into my neck and jaw.
Shingles; COVID VACCINE ISSUE/FEVER; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles) and PYREXIA (COVID VACCINE ISSUE/FEVER) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. In 2021, the patient experienced PYREXIA (COVID VACCINE ISSUE/FEVER). In April 2022, the patient experienced HERPES ZOSTER (Shingles). The patient was treated with VALACICLOVIR HYDROCHLORIDE (VALTREX) at an unspecified dose and frequency. At the time of the report, HERPES ZOSTER (Shingles) and PYREXIA (COVID VACCINE ISSUE/FEVER) outcome was unknown.            No concomitant medication were provided It was reported that with respect to  HUMIRA Product for shingles Action taken was given as unknown, causality will be not reported and de challenge  Is not applicable  and for fever action taken unknown causality not reported  and de challenge is Not applicable.
no adverse event; patient received a dose of PROQUAD and VARIVAX concomitantly when the patient was supposed to receive MMR-II and VARIVAX instead of PROQUAD; patient received a dose of PROQUAD and VARIVAX concomitantly when the patient was supposed to receive MMR-II and VARIVAX instead of PROQUAD; This spontaneous report as received from a practical nurse refers to a patient of unknown age and gender. On 20-JAN-2023, the patient was vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (dose, route and lot # not reported) and a dose of virus vaccine live (oka/merck) (VARIVAX) (dose, route and lot # not reported) (overdose/wrong product administered). The nurse reported that the patient was supposed to receive measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and virus vaccine live (oka/merck) (VARIVAX) instead of varicella (oka-merck) virus vaccine live (PROQUAD).
pt recvd vax & 2 days later exp a generalized pruritic erythematous rash; tx DPH;
Pt. seen by Dr. on 2/14/11. Diagnosed with shingles outbreak. Prescribed Valacyclovir and Pramoxine.
CoVid like symptoms including fever to 101 plus, body aches, pain at site, headache, fatigue
continued as intermittent issue for several months, some time lower tone of ringing; 1st dose 26Aug2021/ 2nd dose 01Dec2021; This is a spontaneous report received from a contactable reporter(s) (Other HCP).  A 48-year-old female patient received BNT162b2 (BNT162B2), on 01Dec2021 at 11:02 as dose 2, single (Lot number: FF2589) at the age of 48 years intramuscular, in right deltoid for covid-19 immunisation. The patient's relevant medical history included: "Sinusitis", start date: 26May2021 (ongoing), notes: Pertinent details: Endoscopic procedure in November D/T sinus re-alleviant injection; "Rhinosinusitis Chronic" (unspecified if ongoing). Concomitant medication(s) included: FLONASE [FLUTICASONE PROPIONATE] nasal taken for sinusitis, start date: Sep2021 (ongoing); BUDESONIDE nasal taken for sinusitis, start date: Nov2021 (ongoing); BENADRYL oral taken for sinusitis, start date: 2020 (ongoing); CLARITIN [LORATADINE] oral taken for sinusitis, start date: 2020 (ongoing). Vaccination history included: BNT162b2 (Dose Number: 1, Date: 26Aug2021, Time (24 hr): 1104, Site and route of injection: Left deltoid, Route of administration: Intramuscular, Batch/lot number: FD0809), administration date: 26Aug2021, when the patient was 48-year-old, for COVID-19 immunization, reaction(s): "moderate hearing loss", "ear ringing/ringing bilateral ear", "sinus re-current infection", "sinus re-current infection". The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 01Dec2021 at 11:02, outcome "unknown", described as "1st dose 26Aug2021/ 2nd dose 01Dec2021"; TINNITUS (non-serious), outcome "not recovered", described as "continued as intermittent issue for several months, some time lower tone of ringing".  Additional information: Reporter was unsure if the Pfizer product had a causal effect to the adverse event. Vaccine facility type was workplace clinic. Vaccine was not administered at private facility. Prior vaccinations was reported as none. Report ongoing ringing bilateral ears approximately starting 2 hours with 1st vaccine. During ENT procedure ears were evaluated. Patient told ear issue or treatable concerns/ signs they noted for her ringing. Continued as intermittent issue for several months, some time lower tone of ringing that does not cause as much disruption. No specific relevant test for thromboembolic events with thrombocytopenia.
Noticed SOB within 2 hours after vaccine. SOB lasted about 24 hours. Also injection site is hot, red, swollen about 2 inches in diameter within 12 hours after injection.
Per patient after 15 minutes she was having to take deep breathes and heart rate increased.  Vitals were taken and heart rate and blood pressure were extremely high. Client sent ER per 911 and was released to home later that day.
Minor pain right arm; Minor pain right arm; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 28Jan2021 14:00 (Lot number: EL3249) at the age of 73 years as 1st dose, single for covid-19 immunisation. Relevant medical history included: "Prostate cancer" (unspecified if ongoing). Concomitant medication(s) included: CYCLOBENZAPRINE; HYDROCHLOROTHIAZIDE. Past drug history included: Lupron, reaction(s): "Lupron: was wearing off". The following information was reported: PAIN IN EXTREMITY (non-serious), CONDITION AGGRAVATED (non-serious) all with onset 29Jan2021, outcome "recovered" (Jan2021) and all described as "Minor pain right arm". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Medications that the patient received within 2 weeks of vaccination was 10mg of Cyclobenzaprine, 25mg of Hydrochlorothiazide. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. He got the first vaccine on 28Jan2021, at (withheld) hospital in right shoulder. He only experienced minor pain in right arm that only lasted a day or two. That is the reaction he had to the vaccine. He would be happy to speak with anyone to report. The pain has subsided quite a bit, although it has not completely gone away. It is discouraging to have lack of energy and wanting to sleep all day.The patient had taken treatment drug tylenol for events occurred after second dose.  No follow-up attempts are possible. No further information is expected.
Tingling and numbness in my R arm (same arm where the flu shot was administered) all the way down the arm to the hand, mainly on my pinky and ring finger.  Symptoms lasted approximately 12 hours.
I had an adverse reaction to the first dose I received on 03/04/2021, but I neglected to report it. My arm was sore for 2 weeks, and on the 9th day I had Covid arm which lasted about 3-4 days.  Swollen, very sore, itchy, red patch which got bigger and bigger. That was also my left arm.  With the second dose, I woke up about 2:00 am with a very sore arm and feeling unwell. I had taken two Tylenol in the evening for my sore arm. I took two more. Yesterday morning, I felt body aches, so this time I took a Motrin around 1:00 pm. By 4:30 pm, I was feeling awful. Achy, feverish and terrible chills. I couldn't stop shaking for a few hours. I took another Motrin around 7:00 pm which seemed to help for a few hours. I didn't measure my temperature, but it felt high. This morning, I'm feeling better, no chills, but I still have 100.3 fever.
Uncomfortable tightness/pressure in chest, shortness of breath coming on in mid-morning, worsening with deep breaths or exertion and improving with rest, gradually improving through the evening and night.  Not accompanied by elevated heart rate or light-headedness.  These symptoms existed alongside expected post-vaccination side effects (joint and muscle aches).
No adverse effects reported; patient inadvertently received first dose of MMR II past its expiration date; This spontaneous report was received from a licensed practical nurse and refers to a 3 year old patient, of unknown gender. Information regarding the patient's pertinent medical history, concurrent conditions, concomitant and historical drugs, drug reactions and allergies was not provided.  On 07-MAY-2019, the patient was inadvertently vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) first dose, lot # N013869, expiration date 04-MAY-2019, subcutaneously (strength and anatomical location were not provided) for prophylaxis. No adverse effects were reported.